Lou Gehrig's disease drug failure pushes Cytokinetics stock lower

Cytokinetics Inc. stock plummeted more than 60 percent by mid-day Friday after the company said its experimental drug to treat amyotrophic lateral sclerosis failed a mid-stage trial...